跳至主要内容
临床试验/IRCT20200324046851N1
IRCT20200324046851N1招募中2 期

Effects of nano curcumin supplementation on the reduction of inflammation and mortality in patients with coronavirus 2019 admitted to ICU ward of Imam Reza hospital in Tabriz

Tabriz University of Medical Sciences0 个研究点目标入组 86 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Confirmation of positive for coronavirus by RT-pcr
  • Willingness to cooperate
  • In accordance with clinical diagnosis or etiologic criteria for coronavirus pneumonia (COVID-19).
  • Able to sign informed consent

排除标准

  • Nutrition and antioxidant supplements and alpha lipoic acid during one month before study
  • Pregnancy and lactation
  • Severe immune suppression (HIV infection, long-term use of immunosuppressive agents)
  • Unwillingness to continue cooperation

研究者

相似试验